Dr. Jean-Yves Douillard: What You Need to Know About Gastrointestinal Studies Presented at ESMO

OncologySTAT Editorial Team. 2010 Oct 25, Interview by L Scott Zoeller

Dr. Douillard is Professor of Medical Oncology at the University of Nantes (France), Director of Clinical and Translational Research at Rene Gauducheau Cancer Center Nantes (France). To learn more, view his profile. Several important studies of gastrointestinal (GI) malignancies presented at the 35th Annual ESMO Congress in Milan are important to clinical practice, including those concerning esophageal, gastric, pancreatic, and colorectal tumors.Esophageal cancerOncologySTAT: Would you discuss the...

NOT A MEMBER?

Registration is FREE

  • Up-to-date oncology news
  • Journal article summaries
  • Commentaries and interviews
  • Drug and interactions database
  • Chemotherapy regimens
  • Daily e-newsletters

 

Meet Our Experts

Meet our Advisory and Editorial Boards comprised of physician editors and world-renowned experts.

Editors' Choice

Everolimus Plus Tamoxifen Improves Survival in Metastatic Breast Cancer

Cancer Type

  • Bladder
  • Bone
  • Breast
  • Breast (ER-Positive)
  • CNS/Brain
  • Colon and Rectum
  • Endocrine System
  • Esophagus
  • GYN (Non-Ovary)
  • GYN (Ovary)
  • Head and Neck
  • Hodgkin's Lymphoma
  • Kidney (Renal Cell)
  • Leukemia
  • Liver and Bile Duct
  • Lung
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • Myeloproliferative Diseases
  • Non-Hodgkin's Lymphoma
  • Pancreas
  • Pediatric Cancers
  • Prostate
  • Rare Cancers
  • Skin
  • Soft-Tissue Sarcoma
  • Stomach
  • Testicle
  • Forgot your password?
    Not a member? Free registration